Risk of serious bloodstream infections is low in pediatric hematopoietic stem cell transplant (HSCT) recipients with fevers due to antithymocyte globulins and alemtuzumab

Biljana Horn,Sara O'Kane,Rachel L. Wattier,Justin T. Wahlstrom,Alexis Melton,M.J. Cowan,Christopher C. Dvorak

Risk of serious bloodstream infections is low in pediatric hematopoietic stem cell transplant (HSCT) recipients with fevers due to antithymocyte globulins and alemtuzumab

2016

Biljana Horn
Sara O'Kane
Rachel L. Wattier
Justin T. Wahlstrom
Alexis Melton
M.J. Cowan
Christopher C. Dvorak

Risk of serious bloodstream infections is low in pediatric hematopoietic stem cell transplant (HSCT) recipients with fevers due to antithymocyte globulins and alemtuzumab

Keywords:

Stem cell
Hematopoietic stem cell transplantation
Progenitor cell
Graft-versus-host disease
Immunology
Alemtuzumab
Bacteremia
Transplantation
Hematopoietic stem cell
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations